Dolly Parton's major Vanderbilt donation supported COVID-19 vaccine
In April, the country legend donated $1 million to the Vanderbilt University Medical Center. Part of her gift went toward research for Moderna's new vaccine.
Drugmaker AstraZeneca says that late-stage trials show its COVID-19 vaccine is highly effective, buoying the prospects of a relatively cheap, easy-to-store product that may become the vaccine of choice for the developing world (Nov 23) The US drug company Pfizer Inc says its experimental COVID-19 vaccine, developed with German firm BioNTech SE, is more than 90 percent effective in late-stage trials.
The news comes as a major victory in the fight against a pandemic that has killed more than a million people, battered the world's economy, and upended daily life.
Pfizer and BioNTech SE are the first drugmakers to release successful data from a large-scale clinical trial of a COVID-19 vaccine.
More than a billion doses could be administered next year.
BioNTech SE admitted they are still waiting on more results to further prove its safety.
Al Jazeera's Charlie Angela reports. AstraZeneca says late-stage trials showed that its COVID-19 vaccine candidate with Oxford University was up to 90 per cent effective in preventing disease. AstraZeneca is the third major drug company to report late-stage results for its potential vaccine.
»» The UK has become the first country to approve the Pfizer-BioNTech COVID-19 vaccine for public use.
It will start to be administered to high priority groups within days.
It is a major breakthrough in the effort to tackle a disease that has killed nearly 1.5 million people around the world.
Al Jazeera's Paul Brennan reports from London.